Wir sind mit live! Mehr erfahren

Pediatrix Medical

MD

Börsenwert 2,22 Mrd. $

27,38 USD

-0,38

1,37 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

27,38

0,00

0 %

1 Tag

-1,37 %

5 Tage

2,78 %

1 Monat

4,78 %

3 Monate

3,95 %

6 Monate

23,28 %

Seit Jahresbeginn

28,6 %

1 Jahr

69,01 %

5 Jahre

4,54 %

10 Jahre

-58,26 %

Profil: Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

Mitarbeiter: 2.260

Gesundheitswesen Medizinische Versorgungseinrichtungen

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 78,6 %

Neutral 21,4 %

Negativ 0 %

Zacks Investment Research

Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term

HB Wealth Expands Into Texas With Experienced Three-Advisor Team

ATLANTA--(BUSINESS WIRE)--HB Wealth, one of the nation's largest independent, fee-only registered investment advisers, today announced that Steven D. Podnos, MD, MBA, CFP®, Rachel Podnos O'Leary, JD, CFP®, and Lauren Podnos-Garner, CFP®, have joined the firm. Together, the three advisors establish the firm's presence in Austin, Texas, with Rachel and Lauren based in Austin and Steven dividing his time between Austin and Cocoa Beach, Florida. The trio previously operated Wealth Care LLC, an inde.

HB Wealth Expands Into Texas With Experienced Three-Advisor Team

Zacks Investment Research

Can Pediatrix Sustain Growth Despite Lower Patient Volumes?

MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.

Can Pediatrix Sustain Growth Despite Lower Patient Volumes?

Zacks Investment Research

Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term

Zacks Investment Research

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

Zacks Investment Research

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Zacks Investment Research

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

Zacks Investment Research

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

Zacks Investment Research

Pediatrix Medical Tops Q2 Earnings on Better Cash Collections

MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.

Pediatrix Medical Tops Q2 Earnings on Better Cash Collections

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt